IMatinib N-ForMyl IMpurity, identified by the CAS number 1256080-09-7, is a chemical compound related to imatinib, a well-known tyrosine kinase inhibitor used primarily in the treatment of certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). This specific impurity is characterized by its structural modifications that may affect the pharmacological properties of the parent compound. Impurities like this can arise during the synthesis of pharmaceuticals and may influence the drug's efficacy, safety, and stability. The presence of impurities is a critical consideration in drug development and quality control, as they can alter the drug's behavior in biological systems. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are typically employed to identify and quantify such impurities. Understanding the characteristics of impurities like IMatinib N-ForMyl is essential for ensuring the safety and effectiveness of the final pharmaceutical product.

IMatinib N-ForMyl IMpurity

1256080-09-7: IMatinib N-ForMyl IMpurity, identified by the CAS number 1256080-09-7, is a chemical compound related to imatinib, a well-known tyrosine kinase inhibitor used primarily in the treatment of certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). This specific impurity is characterized by its structural modifications that may affect the pharmacological properties of the parent compound. Impurities like this can arise during the synthesis of pharmaceuticals and may influence the drug's efficacy, safety, and stability. The presence of impurities is a critical consideration in drug development and quality control, as they can alter the drug's behavior in biological systems. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are typically employed to identify and quantify such impurities. Understanding the characteristics of impurities like IMatinib N-ForMyl is essential for ensuring the safety and effectiveness of the final pharmaceutical product.

CAS 1256080-09-7

IMatinib N-ForMyl IMpurity

Imatinib Diamine N1-Formyl N3-Methyl Impurity

Ref: ST-EA-CP-I5031